Ohio Public Employees Retirement System (OPERS)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Other funds holding APLS
ACA
PCM
DTC
Ohio Public Employees Retirement System (OPERS)'s APLS Position: Q1 2026 in Review
Ohio Public Employees Retirement System (OPERS) reduced its Apellis Pharmaceuticals (APLS) stake by 3.3% in Q1 2026, selling an estimated $23.1K and leaving 31,378 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1241.
Ohio Public Employees Retirement System (OPERS) first reported a position in APLS in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.11M in Q2 2023. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.
- Ohio Public Employees Retirement System (OPERS) held 31,378 shares of Apellis Pharmaceuticals worth $1.26M as of Q1 2026.
- Ohio Public Employees Retirement System (OPERS) sold 1,070 Apellis Pharmaceuticals shares in Q1 2026, an estimated $23.1K.
- Apellis Pharmaceuticals made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1241 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Apellis Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
- Ohio Public Employees Retirement System (OPERS)'s Apellis Pharmaceuticals position peaked at $4.11M in Q2 2023.
- 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.